ATE544470T1 - Immuntherapeutische methoden und zusammensetzungen - Google Patents

Immuntherapeutische methoden und zusammensetzungen

Info

Publication number
ATE544470T1
ATE544470T1 AT01929778T AT01929778T ATE544470T1 AT E544470 T1 ATE544470 T1 AT E544470T1 AT 01929778 T AT01929778 T AT 01929778T AT 01929778 T AT01929778 T AT 01929778T AT E544470 T1 ATE544470 T1 AT E544470T1
Authority
AT
Austria
Prior art keywords
antigen presenting
presenting cells
compositions
relates
immunotherapeutic methods
Prior art date
Application number
AT01929778T
Other languages
English (en)
Inventor
James Dobbie
Original Assignee
Lamellar Biomedical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lamellar Biomedical Ltd filed Critical Lamellar Biomedical Ltd
Application granted granted Critical
Publication of ATE544470T1 publication Critical patent/ATE544470T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT01929778T 2000-03-24 2001-03-26 Immuntherapeutische methoden und zusammensetzungen ATE544470T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0007150.6A GB0007150D0 (en) 2000-03-24 2000-03-24 Immunotherapeutic methods and compositions
PCT/GB2001/001936 WO2001072277A2 (en) 2000-03-24 2001-03-26 Immunotherapeutic methods and compositions

Publications (1)

Publication Number Publication Date
ATE544470T1 true ATE544470T1 (de) 2012-02-15

Family

ID=9888324

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01929778T ATE544470T1 (de) 2000-03-24 2001-03-26 Immuntherapeutische methoden und zusammensetzungen

Country Status (13)

Country Link
US (2) US20040110695A1 (de)
EP (1) EP1267924B1 (de)
JP (1) JP2004517031A (de)
AT (1) ATE544470T1 (de)
AU (2) AU2001256461B2 (de)
CA (1) CA2404325C (de)
DK (1) DK1267924T3 (de)
ES (1) ES2382070T3 (de)
GB (1) GB0007150D0 (de)
NO (1) NO333157B1 (de)
NZ (1) NZ522058A (de)
PT (1) PT1267924E (de)
WO (1) WO2001072277A2 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0007150D0 (en) * 2000-03-24 2000-05-17 Lamellar Therapeutics Limited Immunotherapeutic methods and compositions
GB0207653D0 (en) * 2002-04-03 2002-05-15 Lamellar Therapeutics Ltd Methods of using lamellar bodies for therapeutic purposes
ATE552843T1 (de) * 2003-02-06 2012-04-15 Aduro Biotech Listerien deren eindringen in nicht-phagozytische zellen abgeschwächt ist, impfstoffe, die diese listerien enthalten und deren verwendungen
US11324698B2 (en) * 2003-08-28 2022-05-10 Vgsk Technologies, Inc. Sterically stabilized carrier for aerosol therapeutics, compositions and methods for treating the respiratory tract of a mammal
WO2005030226A1 (en) * 2003-09-25 2005-04-07 Lamellar Therapeutics Limited Compositions and methods of using lamellar bodies for therapeutic purposes
GB0322448D0 (en) 2003-09-25 2003-10-29 Lamellar Therapeutics Ltd Using lamellar bodies to modify linear biological macro molecules
AU2005259685B2 (en) * 2004-07-07 2010-04-08 Statens Serum Institut Compositions and methods for stabilizing lipid based adjuvant formulations using glycolipids
US20070299431A1 (en) 2006-05-02 2007-12-27 Green Medical, Inc. Systems and methods for treating superficial venous malformations like spider veins
US7465312B2 (en) 2006-05-02 2008-12-16 Green Medical, Inc. Systems and methods for treating superficial venous malformations like spider veins
JP5667180B2 (ja) * 2009-07-01 2015-02-12 イオン メディックス インコーポレイテッド 哺乳類の有核細胞に由来するマイクロベシクル及びその用途
WO2012002759A2 (ko) 2010-07-01 2012-01-05 포항공과대학교 산학협력단 세포의 원형질체에서 유래한 마이크로베시클 및 이의 용도
CN107115314B (zh) * 2011-06-02 2022-04-29 加利福尼亚大学董事会 膜包封的纳米颗粒及使用方法
WO2015021390A2 (en) 2013-08-08 2015-02-12 The Regents Of The University Of California Nanoparticles leverage biological membranes to target pathogens for disease treatment and diagnosis
WO2015084677A1 (en) 2013-12-02 2015-06-11 Arytha Biosciences, Llc Toxoid preparation and uses thereof
WO2015143295A2 (en) 2014-03-20 2015-09-24 The Regents Of The University Of California Hydrogel compositions containing toxin-absorbing or binding nanoparticles and uses thereof
US11110127B2 (en) 2014-06-02 2021-09-07 Cellics Therapeutics, Inc. Use of nanoparticles coated with red blood cell membranes to treat hemolytic diseases and disorders
US10434070B2 (en) 2015-01-02 2019-10-08 Cellics Therapeutics, Inc. Use of nanoparticles coated with red blood cell membranes to enable blood transfusion
US10610493B2 (en) 2015-04-29 2020-04-07 The Regents Of The University Of California Detoxification using nanoparticles
CN108289845A (zh) 2015-09-14 2018-07-17 维吉思康科技公司 皮下、舌下和口服治疗用空间稳定载体、用于治疗哺乳动物的组合物和方法
EP3632410A1 (de) 2018-10-05 2020-04-08 Lamellar Biomedical Limited Lipidische polynukleotidträger für die zellabgabe
JP2021536257A (ja) 2018-09-06 2021-12-27 イェディテペ・ウニヴェルシテシYeditepe Universitesi 免疫系細胞に対する調節効果を示すための植物エクソソームの使用
EP3692984A1 (de) 2019-02-08 2020-08-12 Deutsches Krebsforschungszentrum, Stiftung des öffentlichen Rechts Annexinbeschichtete partikel
AU2022270670A1 (en) 2021-05-05 2023-11-30 Nejat Duzgunes Liposome-encapsulated corticosteriods inhibit sars-cov-2 replication and reduces lung inflammation

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5925375A (en) * 1987-05-22 1999-07-20 The Liposome Company, Inc. Therapeutic use of multilamellar liposomal prostaglandin formulations
US5403592A (en) * 1987-08-25 1995-04-04 Macnaught Pty Limited Lubricant composition for rheumatism
US5006343A (en) * 1988-12-29 1991-04-09 Benson Bradley J Pulmonary administration of pharmaceutically active substances
FR2645878B1 (fr) * 1989-04-17 1994-02-25 Institut Nal Sante Recherc Medic Sequences nucleotidiques d'actinomycetales, applications a la synthese ou a la detection d'acides nucleiques, produits d'expression de ces sequences et application en tant que compositions immunogenes
US5088499A (en) * 1989-12-22 1992-02-18 Unger Evan C Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same
AU665764B2 (en) * 1991-05-29 1996-01-18 Baxter International Inc. Methods and compositions for the prevention, diagnosis, and treatment of inflammatory serosal disease and related conditions
JPH05339169A (ja) * 1992-03-03 1993-12-21 Dai Ichi Seiyaku Co Ltd 経口ワクチン
US5543152A (en) * 1994-06-20 1996-08-06 Inex Pharmaceuticals Corporation Sphingosomes for enhanced drug delivery
US5462752A (en) * 1994-07-28 1995-10-31 Prp, Inc. Inhibition of platelet binding
US5643599A (en) * 1995-06-07 1997-07-01 President And Fellows Of Harvard College Intracellular delivery of macromolecules
JPH11510046A (ja) * 1995-07-21 1999-09-07 ローヌ−プーラン ローラー ファーマシューティカルズ インコーポレイテッド アデノ関連ウイルスリポソーム及び樹状細胞をトランスフェクトして特異性免疫を刺激することにおけるそれらの使用
DE69839443D1 (de) * 1997-05-08 2008-06-19 Biomira Inc Verfahren zur gewinnung von aktivierten t-zellen und mit antigen inkubierten antigenpräsentierenden zellen
GB9807298D0 (en) * 1998-04-03 1998-06-03 Britannia Pharmaceuticals Ltd Medicament
EP0976403A1 (de) * 1998-07-30 2000-02-02 Stichting Instituut voor Dierhouderij en Diergezondheid (ID-DLO) Adjuvans das ein Lungensurfactant enthält
US6193997B1 (en) * 1998-09-27 2001-02-27 Generex Pharmaceuticals Inc. Proteinic drug delivery system using membrane mimetics
US6290987B1 (en) * 1998-09-27 2001-09-18 Generex Pharmaceuticals, Inc. Mixed liposome pharmaceutical formulation with amphiphiles and phospholipids
GB0007150D0 (en) * 2000-03-24 2000-05-17 Lamellar Therapeutics Limited Immunotherapeutic methods and compositions
GB0207653D0 (en) * 2002-04-03 2002-05-15 Lamellar Therapeutics Ltd Methods of using lamellar bodies for therapeutic purposes
GB0322448D0 (en) * 2003-09-25 2003-10-29 Lamellar Therapeutics Ltd Using lamellar bodies to modify linear biological macro molecules

Also Published As

Publication number Publication date
DK1267924T3 (da) 2012-05-29
JP2004517031A (ja) 2004-06-10
EP1267924A2 (de) 2003-01-02
NO20024571D0 (no) 2002-09-24
GB0007150D0 (en) 2000-05-17
PT1267924E (pt) 2012-05-24
NZ522058A (en) 2005-05-27
CA2404325A1 (en) 2001-10-04
AU2001256461B2 (en) 2005-06-30
CA2404325C (en) 2012-06-12
ES2382070T3 (es) 2012-06-05
WO2001072277A2 (en) 2001-10-04
NO333157B1 (no) 2013-03-18
NO20024571L (no) 2002-10-14
EP1267924B1 (de) 2012-02-08
US20040110695A1 (en) 2004-06-10
WO2001072277A3 (en) 2002-06-13
US20080069866A1 (en) 2008-03-20
AU5646101A (en) 2001-10-08

Similar Documents

Publication Publication Date Title
DK1267924T3 (da) Immunterapeutiske metoder og sammensætninger
SI2351579T1 (sl) Polipeptidna cepiva za široko zaščito proti hipervirulentnim meningokoknim linijam
NZ331651A (en) BSW17 peptide immunogens for vaccination against and treatment of allergy
IS4518A (is) Nýtt lyfjaform fyrir bóluefni
AU6632496A (en) Cell derived antigen presenting vesicles
WO2005037190A3 (en) Multiplex vaccines
AU3847801A (en) Proteosome influenza vaccine
NO973250L (no) Preparater for avlevering av antigener
IL142948A0 (en) Agents and compositions and methods utilizing same useful in diagnosing and/or treating or preventing plaque forming diseases
TR200002930T2 (tr) Kolaylaştırıcı kompozisyonlar
OA09800A (en) Vaccine compositions containing liposomes.
BR0012424A (pt) Peptìdeos meningocócicos antigênicos
GR3017778T3 (en) Immunogenic complexes, in particular iscoms.
MXPA05013929A (es) Membranas virales reconstruidas funcionalmente que contienen un adyuvante.
ES2177927T3 (es) Composicion para provocar una reaccion inmunologica a un determinante antigenico no proteinico.
CA2232344A1 (en) Compositions and methods for enhancing immune responses mediated by antigen-presenting cells
DE60137347D1 (de) Neuer immunogener komplex
WO2004030616A3 (en) Ii-KEY/ANTIGENIC EPITOPE HYBRID PEPTIDE VACCINES
WO2004033483A3 (en) Liposomal system and method of using same
WO1999047102A3 (en) Methods for enhanced antigen presentation on antigen-presenting cells and compositions produced thereby
DK0952771T3 (da) Hidtil ukendte saponinpræparater og anvendelser deraf
Lugade et al. Lipid motif of a bacterial antigen mediates immune responses via TLR2 signaling
MX9708226A (es) Vacunas que contienen una saponina y un esterol.